Harrisburg, PA – November one, 2018 – Yesterday, Cannabis Regulation PA submitted feedback in response to the FDA’s request for data concerning the “abuse probable, true abuse, professional medical usefulness, trafficking, and impact of scheduling improvements on availability for professional medical use” of hashish. In the course of its responses, Cannabis Legislation PA “encouraged the Food and drug administration to suggest that the Study Extra

LEAVE A REPLY

Please enter your comment!
Please enter your name here